GILDT1

GILEAD SCIENCES, INC.

Financial Intelligence

Scored 11/1/2026

Buffett Quality

8.0/10

Lynch Category

Fast Grower

Margin of Safety

—

Acquisition Risk

Not flagged

Owner Earnings

$9.7B

Recent Signals

11 found
insider_transaction

GILEAD SCIENCES, INC.

is_buy: false · shares: 3000 · filing_date: 2026-10-16

10/16/2026

50%

insider_transaction

GILEAD SCIENCES, INC.

is_buy: false · shares: 3000 · filing_date: 2026-10-16

10/16/2026

50%

insider_transaction

GILEAD SCIENCES, INC.

is_buy: false · shares: 12000 · filing_date: 2026-10-02

10/2/2026

50%

insider_transaction

GILEAD SCIENCES, INC.

is_buy: false · shares: 3000 · filing_date: 2026-10-02

10/2/2026

50%

insider_transaction

GILEAD SCIENCES, INC.

is_buy: false · shares: 4600 · filing_date: 2026-08-27

8/27/2026

50%

insider_transaction

GILEAD SCIENCES, INC.

is_buy: false · shares: 6880 · filing_date: 2026-08-27

8/27/2026

50%

insider_transaction

GILEAD SCIENCES, INC.

is_buy: false · shares: 3402 · filing_date: 2026-08-27

8/27/2026

50%

insider_transaction

GILEAD SCIENCES, INC.

is_buy: false · shares: 3118 · filing_date: 2026-08-27

8/27/2026

50%

insider_transaction

GILEAD SCIENCES, INC.

is_buy: false · shares: 600 · filing_date: 2026-08-04

8/4/2026

50%

insider_transaction

GILEAD SCIENCES, INC.

is_buy: false · shares: 6700 · filing_date: 2026-08-04

8/4/2026

50%

insider_transaction

GILEAD SCIENCES, INC.

is_buy: false · shares: 7700 · filing_date: 2026-08-04

8/4/2026

50%

Watch Reason

S&P 500 / major index component — seeded via EDGAR